Most not too long ago, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a big range of endogenous opioids. As opposed to most opioid receptors, this receptor https://michaeln010myk5.wikipublicist.com/user